Subject: 回复: 【耐性GERD疾病沟通长图文】结算开票申请
From: "Wang, Sining" <[email-masked]>
To: Natalie.bi <[email-masked]>
Cc: '刘媛媛' <[email-masked]>, "Wu, Lei" <[email-masked]>, "Ni, Weiyan (Always)" <[email-masked]>
Date: Mon, 1 Mar 2021 07:47:07 +0000

Dear

确认，烦请开票，谢谢！

Best Regards,
Sining Wang

发件人: Natalie.bi <[email-masked]>
发送时间: 2021年3月1日 15:37
收件人: Wang, Sining <[email-masked]>
抄送: '刘媛媛' <[email-masked]>
主题: 【耐性GERD疾病沟通长图文】结算开票申请

Dear Sining,
耐信5篇长图文已全部完成，结算单和PO如附件，烦请确认如下结算开票信息，谢谢。

开票抬头：阿斯利康（无锡）贸易有限公司
金额：23638元
内容：设计服务费
备注：PO7000115936

BR,
Natalie Bi
13916233296

发件人: Natalie.bi [mailto:[email-masked]]
发送时间: 2021年2月26日 11:31
收件人: 'Ni, Weiyan (Always)' <[email-masked]<mailto:[email-masked]>>
抄送: 'Wu, Lei' <[email-masked]<mailto:[email-masked]>>; 'Wang, Sining' <[email-masked]<mailto:[email-masked]>>
主题: 答复: 【耐性GERD疾病沟通长图文】疗程篇长图文更新

Dear Olivia,
请查收附件4篇的final word版，谢谢。

BR,
Natalie Bi
13916233296

发件人: Ni, Weiyan (Always) [mailto:[email-masked]]
发送时间: 2021年2月25日 17:48
收件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 回复: 【耐性GERD疾病沟通长图文】疗程篇长图文更新

Dear Natalie,
请提供以下4篇的final word版，谢谢
Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年2月25日 15:17
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 答复: 【耐性GERD疾病沟通长图文】疗程篇长图文更新

Dear Olivia,
请查收附件疗程篇长图文（含审批编号和有效期），谢谢。

BR,
Natalie Bi
13916233296

发件人: Ni, Weiyan (Always) [mailto:[email-masked]]
发送时间: 2021年2月25日 12:03
收件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 回复: 【耐性GERD疾病沟通长图文】疾病篇和疗程篇长图文更新

Dear Natalie,

请删除“这些”，如图所示，并添加审批编号 CN-72786 ，有效期至2021-8-24，请出最终版，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年2月25日 11:17
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 答复: 【耐性GERD疾病沟通长图文】疾病篇和疗程篇长图文更新

Dear Olivia,
修改如下：

1.     疾病篇已添加审批编号和有效期，请见附件

2.     疗程篇已修改，请查收长图文、ref、批注回复，谢谢。

BR,
Natalie Bi
13916233296

发件人: Ni, Weiyan (Always) [mailto:[email-masked]]
发送时间: 2021年2月23日 20:05
收件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 回复: 【耐性GERD疾病沟通长图文】疾病篇长图文更新

Dear Natalie,

l  疾病篇-GERD长图文<https://astrazeneca-promomats.veevavault.com/ui/#doc_info/1331743/1/0=&idx=0&pt=myl&sid=&tvsl=JmZjYWg9c3RhdHVzJTJDZG9jdW1lbnRUeXBlJTJDY291bnRyeV9iJTJDcHJvZHVjdCZ2aWV3SWQ9bXkmZmFjZXRzVW5jaGFuZ2VkPWZhbHNlJml2cz1WZXJzaW9uTGFzdE1vZGlmaWVkRGF0ZSZpdm89ZGVzYw,,>已通过审批，审批编码CN-72784，有效期至2022-2-23，请添加并出最终版，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年2月23日 17:45
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 【耐性GERD疾病沟通长图文】疾病篇长图文更新

Dear Olivia,
附件是更新的疾病篇长图文，请查收，疗程篇还在修改中，会尽快发出，谢谢。

BR,
Natalie Bi
13916233296

发件人: Ni, Weiyan (Always) [mailto:[email-masked]]
发送时间: 2021年2月22日 14:08
收件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
抄送: Wu, Lei <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 回复: 【耐性GERD疾病沟通长图文】3篇长图文及文献

Dear Natalie,

l  治疗篇-GERD长图文<https://astrazeneca-promomats.veevavault.com/ui/#doc_info/1331743/1/0=&idx=0&pt=myl&sid=&tvsl=JmZjYWg9c3RhdHVzJTJDZG9jdW1lbnRUeXBlJTJDY291bnRyeV9iJTJDcHJvZHVjdCZ2aWV3SWQ9bXkmZmFjZXRzVW5jaGFuZ2VkPWZhbHNlJml2cz1WZXJzaW9uTGFzdE1vZGlmaWVkRGF0ZSZpdm89ZGVzYw,,>已通过审批，审批编码CN-72787，有效期至2021-12-31，请添加并出最终版，谢谢

l  疗程篇、疾病篇NS老师反馈详见附件，请调整，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: Natalie.bi <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年2月20日 15:52
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>
抄送: Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 【耐性GERD疾病沟通长图文】3篇长图文及文献

Dear Olivia,
附件是更新的3篇长图文以及相关文献包（已高亮引用），请查收，谢谢。

BR,
Natalie Bi
13916233296
------------------ Original ------------------
From:  "Ni, Weiyan (Always)"<[email-masked]<mailto:[email-masked]>>;
Date:  Mon, Feb 8, 2021 02:18 PM
To:  "丁逸凡"<[email-masked]<mailto:[email-masked]>>; "Wang, Sining"<[email-masked]<mailto:[email-masked]>>;
Subject:  回复: 【耐性GERD疾病沟通长图文】四篇长图文及文献

Dear both,
烦请根据NS老师反馈进行调整，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: 丁逸凡 <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年2月5日 14:24
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: Re: 【耐性GERD疾病沟通长图文】四篇长图文及文献

Dear both，
附件为节日篇长图文的最终版，烦请查收。
Best Regards，
Frida

------------------ Original ------------------
From:  "Ni, Weiyan (Always)"<[email-masked]<mailto:[email-masked]>>;
Date:  Fri, Feb 5, 2021 10:55 AM
To:  "丁逸凡"<[email-masked]<mailto:[email-masked]>>; "Wang, Sining"<[email-masked]<mailto:[email-masked]>>;
Subject:  回复: 【耐性GERD疾病沟通长图文】四篇长图文及文献

Dear both,
节日篇-GERD长图文，审批编号 CN-72785,有效期至2022-2-4，请添加并出最终版，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: 丁逸凡 <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年2月4日 18:12
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: Re: 【耐性GERD疾病沟通长图文】四篇长图文及文献

CAUTION: This email originated outside AstraZeneca. Do not open the attachment(s) unless you recognize the sender and know the content is safe.

Dear both，

附件为调整好的四篇长图文及节日篇已highlight的参考文献，烦请查收。

Best Regards，
Frida

------------------ Original ------------------
From:  "Ni, Weiyan (Always)"<[email-masked]<mailto:[email-masked]>>;
Date:  Tue, Feb 2, 2021 07:25 PM
To:  "丁逸凡"<[email-masked]<mailto:[email-masked]>>; "Wang, Sining"<[email-masked]<mailto:[email-masked]>>;
Subject:  回复: 【耐性GERD疾病沟通长图文】四篇长图文及文献

Dears,
四篇长图文请根据批注调整，有两篇今天上午已邮件过，此次再次汇总发送，请查收，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: Ni, Weiyan (Always)
发送时间: 2021年2月2日 11:31
收件人: 丁逸凡 <[email-masked]<mailto:[email-masked]>>; Wang, Sining <[email-masked]<mailto:[email-masked]>>
主题: 回复: 【耐性GERD疾病沟通长图文】四篇长图文及文献

Dear both,
请根据附件批注进行调整，谢谢

Thanks and best regards,
倪唯艳 Olivia Ni
Coordinator Support | REGI CMKT
_____________________________________________________________________________________________

AstraZeneca
China | Commercial Retail Team
Floor 5, No. 199 Liangjing Road, Zhangjiang Hi-Tech Park, Shanghai 201203
M: +86 (0)159 0174 6006
[email-masked]<mailto:[email-masked]>

Please consider the environment before printing this e-mail.

发件人: Wang, Sining <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年1月31日 17:09
收件人: Ni, Weiyan (Always) <[email-masked]<mailto:[email-masked]>>
主题: 转发: 【耐性GERD疾病沟通长图文】四篇长图文及文献

Dear Olivia，

后4篇长图文烦请提交PromoMats审批，谢谢！

Best Regards,
Sining Wang

发件人: 丁逸凡 <[email-masked]<mailto:[email-masked]>>
发送时间: 2021年1月29日 18:55
收件人: Wang, Sining <[email-masked]<mailto:[email-masked]>>
抄送: 毕文君 <[email-masked]<mailto:[email-masked]>>; 刘媛媛 <[email-masked]<mailto:[email-masked]>>
主题: 【耐性GERD疾病沟通长图文】四篇长图文及文献

CAUTION: This email originated outside AstraZeneca. Do not open the attachment(s) unless you recognize the sender and know the content is safe.

Dear Steph，

附件为GERD四篇长图文初稿及四篇文献，烦请查收。

Best Regards，
Frida